Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Cancer Science|May 17, 2022
Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma: Phase IIb resultsAtae Utsunomiya, Koji Izutsu, Tatsuro Jo, et al.
International Journal of Hematology|January 4, 2020
High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpuraKen Takase, Hirokazu Nagai, Moe Kadono, et al.
British Journal of Haematology|June 17, 2014
Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)Takuya Fukushima, Shogo Nomura, Masanori Shimoyama, et al.
British Journal of Haematology|June 26, 2020
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)Dai Maruyama, Shinsuke Iida, Gakuto Ogawa, et al.
In Vivo (Athens, Greece)|October 30, 2024
Real-world Referral Pattern of Unplanned Excision in Patients With Soft-tissue Sarcoma: A Multicenter Study Conducted by the Bone and Soft-tissue Tumor Study Group of the Japan Clinical Oncology GroupTomoki Nakamura, Koichi Ogura, Keiko Hayakawa, et al.
Mycoses|May 12, 2020
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent feverIsao Yoshida, Akiko M Saito, Shiro Tanaka, et al.
Cancer Science|February 12, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyNobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, et al.
Cancer Chemotherapy and Pharmacology|January 24, 2025
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1)Masaki Ri, Shinsuke Iida, Kosuke Saito, et al.
Japanese Journal of Clinical Oncology|September 2, 2025
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphomaKen Ohmachi, Tomohiro Kinoshita, Dai Maruyama, et al.
Cancer Science|August 9, 2020
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 studyYoshitoyo Kagami, Kazuhito Yamamoto, Taro Shibata, et al.
Pageof 15